Wockhardt Share Price

ABOUT Wockhardt

• Industry Biotechnology & Drugs
• ISIN INE049B01025
• BSE Code 532300
• NSE Code WOCKPHARMA

Wockhardt Limited is a research-based global pharmaceutical and biotech company. The Company is engaged in the pharmaceutical business. It focuses on the unmet need for antibacterial drugs that are effective against the menace of untreatable superbugs. It manufactures and supplies branded and generic finished formulations, as well as intermediate products like active pharmaceutical ingredients (APIs), worldwide. The Company’s products in India include EMROK, MERIWOK, REINVEXIN, ERLISO, METHYCOBAL TABLET, METHYCOBAL INJ, METHYCOBAL D, HAPID, PROXYFEN NANO GEL, LIVATIRA TABLET, LIVATIRA INJ, GABAWOK NT 100, GABAWOK NT 400, ETOBRIX 90, ETOBRIX TH4, ETOBRIX P, GLARZEN CARTRIDGE, GLARZEN DISPOPEN 2, ESOWOK D, TERITIDE, GLIMADAY, SITAWOK, GLARITUS, TRIMETADAY, MOPADAY, INOGLA, and ZINODAP. The Company has manufacturing and research facilities in India, United States of America and the United Kingdom and a manufacturing facility in Ireland.

MANAGEMENT

• Habil Fakhruddin Khorakiwala Executive Chairman of the Board
• Deepak Madnani Chief Financial Officer
• Rashmi Mamtura Compliance Officer, Company Secretary
• Murtaza Habil Khorakiwala Managing Director, Executive Director
• Huzaifa Habil Khorakiwala Executive Director